HOME › DRUGS › DALFAMPRIDINE
ACTIVE SUBSTANCE / INN

DALFAMPRIDINE

Brand name(s): DALFAMPRIDINE, AMPYRA
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA206646
NDA022250
ACTIVE SUBSTANCE
Dalfampridine
REGULATORS
FDA
SPONSORS / MAH
ACCORD HLTHCARE, HIKMA, MERZ
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DALFAMPRIDINEANDA206863ACCORD HLTHCAREPrescription
DALFAMPRIDINEANDA206646HIKMADiscontinued
AMPYRANDA022250MERZPrescription
DALFAMPRIDINEANDA206854TEVA PHARMS USA INCNone (Tentative Approval)

FULL INTELLIGENCE ON DALFAMPRIDINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →